NEW YORK ( TheStreet) -- Kensey Nash Corporation (Nasdaq: KNSY) hit a new 52-week high Monday as it is currently trading at $38.50, above its previous 52-week high of $38.49 with 28,430 shares traded as of 10:13 a.m. ET. Average volume has been 96,800 shares over the past 30 days. Kensey Nash has a market cap of $332.4 million and is part of the health care sector and health services industry. Shares are up 99.7% year to date as of the close of trading on Friday. Kensey Nash Corporation, a medical device company, engages in the field of regenerative medicine products and technologies to help repair damaged or diseased tissues. The company has a P/E ratio of 201.7, below the average health services industry P/E ratio of 273.8 and above the S&P 500 P/E ratio of 17.7.
TheStreet Ratings rates Kensey Nash as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income, good cash flow from operations, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Kensey Nash Ratings Report. See all 52-week high stocks or get investment ideas from our investment research center.
Shares of Kensey Nash Corporation (Nasdaq:KNSY) were gapping up Thursday morning with an open price 32.3% higher than Wednesday's closing price. The stock closed at $29.01 yesterday and opened today's trading at $38.37.